Entrust Financial’s Dare Bioscience DARE Stock Holding History

Entrust Financial’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$427	Buy	+500	New	+$585	﹤0.01%	502

Other funds holding DARE

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Garde Capital Seattle, Washington $1.8B AUM 11.9% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Jacobi Capital Management Pittston, Pennsylvania $2.11B AUM 19.6% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Entrust Financial's DARE Position: Q3 2026 in Review

Entrust Financial opened a new position in Dare Bioscience (DARE) in Q3 2026: 500 shares worth $427. The stake represents ﹤0.01% of the portfolio and ranks #502 among its holdings.

15 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

Entrust Financial held 500 shares of Dare Bioscience worth $427 as of Q3 2026.
Dare Bioscience was a new Entrust Financial position in Q3 2026.
Dare Bioscience made up ﹤0.01% of Entrust Financial's portfolio in Q3 2026, its #502 holding.
15 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on Entrust Financial's 13F filing for Q3 2026, filed 4 Nov 2026.